Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine in Early HIV Infection
NCT00308620Phase 3Terminated
- Sponsor
- University of Minnesota
- Start
- Mar 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of chloroquine in human immunodeficiency virus infection (HIV) (3 arms), sponsored by University of Minnesota. Primary endpoint: HIV Viral Load Change at 8 weeks. Started Mar 2006; status: terminated.
02
Drugs
chloroquine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00308620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00308620.